The Latest Trends and Potential Implications in Rare Disease, Orphan Drug Management | Asembia Specialty Pharmacy Summit

Results of the Alnylam Rare Disease Trend report were shared at this year's Asembia Specialty Pharmacy Summit.

Some key rare disease trends include the increased focus in rare disease management, sites of care policies increasing, uncertainty around recent federal legislation and how these changes will affect payers and rare disease industry.